[Remote] Clinical Science - Medical Science Liaison (Sr.) at Tempus

Massachusetts, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

HealthcareIndustries

Requirements

Advanced scientific or medical degree (PhD, PharmD, MD, MSN, BSN)
Fundamental understanding of molecular oncology, comprehensive genomic profiling, tumor evolution, and relevant targeted therapy options in early and advanced stage cancer, with ability to interpret clinical trial data
Basic understanding of oncology (required); basic understanding of molecular testing (strongly preferred)
Existing KOL relationships in the field of oncology
Working knowledge of genomic laboratory-developed testing (LDT) with tissue and liquid biopsy; familiarity with CLIA-88’, CAP, Sunshine Act (2013)
Proficient public speaking skills with ability to effectively communicate clinical data and complex scientific concepts
Exceptional interpersonal communication skills, strong inter- and intradepartmental management skills, ability to educate and train
Self-starter who can work autonomously to deliver on tight timelines
Ability to travel 50%
Residing in RI/MA/NH (considered candidates)
Preferred: 1+ years of MSL experience in diagnostics, biotech or pharmaceutical industries

Responsibilities

Serve as a subject matter expert supporting commercial team efforts with deep and current understanding of the oncology landscape, including diagnostic tests, disease states, treatment paradigms, and emerging biomarkers and technologies
Build relationships with Key Opinion Leaders (KOLs) and other HCP experts, including oncologists, pathologists, lab directors, and researchers
Deliver scientific presentations and promote exchange of clinical/scientific/technical information with regional KOLs, community physicians, medical directors, and other HCPs in the field of oncology, including proactive and reactive communication of scientific data
Facilitate discussions for insights in clinical research, unmet needs, and emerging trends in testing practices
Provide scientific education for internal stakeholders in collaboration with Learning & Development team
Continuously update internal stakeholders on relevant medical and scientific insights as well as proactively sharing market intelligence

Skills

Oncology

Genomic Profiling

Medical Science Liaison

KOL Engagement

Scientific Presentations

Biomarkers

Diagnostic Tests

Treatment Paradigms

Precision Medicine

Clinical Research

Tempus

AI-driven healthcare data analysis platform

About Tempus

Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where their research has shown increased opportunities for tailored treatments. They have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Tempus generates revenue by charging healthcare providers and companies for access to their platform and insights, setting them apart from competitors by their focus on personalized medicine and extensive cancer research.

Chicago, IllinoisHeadquarters

2015Year Founded

$894.9MTotal Funding

IPOCompany Stage

AI & Machine Learning, Biotechnology, HealthcareIndustries

1,001-5,000Employees

Benefits

Relocation Assistance

Company Equity

Performance Bonus

Risks

Competition from partners like Genialis may lead to conflicts of interest.

Ambry Genetics acquisition could pose financial risks if synergies aren't realized.

Technical challenges may arise in integration with Flatiron's OncoEMR platform.

Differentiation

Tempus uses AI to analyze clinical and molecular data for precision medicine.

Their platform aids in personalized treatment decisions for cancer patients.

Tempus collaborates with biotech firms to enhance drug development using real-world data.

Upsides

Increased AI adoption in healthcare boosts Tempus' partnerships and collaborations.

Acquisition of Ambry Genetics expands Tempus' genetic testing capabilities.

Integration with Flatiron's OncoEMR enhances precision in cancer treatment plans.

Land your dream remote job 3x faster with AI

Try Jobo Free